Atlas Trials

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)

Clinical trial NCT04183868 · COMPLETED

Trial details

NCT number
NCT04183868
Sponsor
University of Catanzaro
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesCardiovascular Risk Factor
Start date
2016-04-01
Primary completion
2021-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.